Empagliflozin And Linagliptin Tablets Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

 

Generic name	Empagliflozin and Linagliptin Tablets
Trade name	Glyxambi
Specification	10mg/5mg
Main ingredients	Empagliflozin and Linagliptin
Dosage Form	Tablet
MA Holder	Boehringer Ingelheim Pharmaceuticals, Inc.
Category	Reference Listed Drugs (RLDs)

 

Indications:
This medication is a combination of 2 drugs: empagliflozin and linagliptin. It is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Linagliptin works by increasing levels of natural substances called incretins.

 

For more details, pls contact Janney:

Email: tosun-global@upharm.cn

Wechat/Whatsapp:(+86)18922120575

Hot Tags: empagliflozin and linagliptin tablets reference listed drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Alfacalcidol Soft Capsules, Acarbose Tablets, Argatroban Injection, Agomelatine Tablets, Adefovir Dipivoxil Tablets, Bimatoprost Ophthalmic

• Previous: Oxybutynin Hydrochloride Sustained Release Tablets Reference Listed Drug
• Next: Potassium Chloride Extended Release Capsules Reference Listed Drug